about
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.Longevity of popes and artists between the 13th and the 19th centuryIncreased Uptake of HCV Testing through a Community-Based Educational Intervention in Difficult-to-Reach People Who Inject Drugs: Results from the ANRS-AERLI StudyCorrelates of general practitioners' recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (A/H1N1) in France: implications for future vaccination campaigns.The macroeconomic consequences of renouncing to universal access to antiretroviral treatment for HIV in Africa: a micro-simulation model.Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study.Thrombosis and antiphospholipid antibody syndrome during acute Q fever: A cross-sectional study.Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.Pain in methadone patients: Time to address undertreatment and suicide risk (ANRS-Methaville trial)The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.HCV seropositivity in inmates and in the general population: an averaging approach to establish priority prevention interventions.Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville).Blood agar and Mycobacterium tuberculosis: the end of a dogma.Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventionsImpact of HIV comprehensive care and treatment on serostatus disclosure among Cameroonian patients in rural district hospitals.Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study20-years of population-based cancer registration in hepatitis B and liver cancer prevention in the Gambia, West AfricaScaling up combined community-based HIV prevention interventions targeting truck drivers in Morocco: effectiveness on HIV testing and counselingInvestigating Recent Testing among MSM: Results from Community-Based HIV Rapid Testing Attendees in France.Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach.Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concernObesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii.The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus.Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trialHIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks.Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).Treatment and Prophylactic Strategy for Coxiella burnetii Infection of Aneurysms and Vascular Grafts: A Retrospective Cohort Study.Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014.Tropheryma whipplei DNA in bronchoalveolar lavage samples: a case control study.Visiting one's native country: the risks of nonadherence in HIV-infected sub-Saharan migrants--ANRS VIHVO study.Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort.Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial).Antiphospholipid Antibody Syndrome With Valvular Vegetations in Acute Q Fever.B-cell non-Hodgkin lymphoma linked to Coxiella burnetii.Reevaluation of the risk of fetal death and malformation after Q Fever.Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepA reduced factor structure for the PROQOL-HIV questionnaire provided reliable indicators of health-related quality of life.Adding HCV treatment to HIV treatment in HIV-HCV coinfected patients: the impact on the different dimensions of fatigue and self-reported side effects.Suicidal risk among patients enrolled in methadone maintenance treatment: HCV status and implications for suicide prevention (ANRS Methaville).Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions.
P50
Q27824864-773DEB39-6EF9-4991-B464-05F93BEA2660Q28279688-E8FBB24B-601A-40F1-BEF1-F9D3C55C637BQ28550235-FD03F2A0-B5C8-4CF2-839F-B3CD76B9176FQ30360235-AF51744A-A0A9-4740-B743-4188FB4EB857Q30415562-504BB33F-0409-4E4E-9161-E3F73A681028Q31076943-77189163-718B-4559-8694-C1701DDF3242Q33443797-6B5806D8-4680-46BF-8ADC-17BCB19A34F5Q33592665-C9A3F0BE-DAF8-41B5-8812-0109BD6A609AQ33698816-F0BA9B45-D0EF-4A54-B575-9FCE60FC0CECQ33726091-CEBA342D-6715-4B79-9B89-14D2A496D7F7Q34365104-B4ED7703-6B95-4B99-87DA-0D4573FB5A16Q34506560-29AA8D20-1334-4467-9461-50157914FE91Q34532630-B16DCB23-F698-4FC0-AE2C-15A330A15600Q34545139-828A6504-DF8B-4729-ADBF-6F1367EC763FQ34576235-710CE115-8752-4D6A-AA40-87CE5D4CDE54Q34903835-4F7DA490-63D0-4BBB-B0FB-C9B38EBA909BQ35010094-553294C7-7551-464E-8614-258816C16AEBQ35588275-C84CC7ED-F2F3-4234-A72D-977CBAD9C7F3Q35623713-0EFA9696-A09F-49F8-A2F0-617EB4BF45C5Q35777089-1E84B39D-E4E3-4563-8FA1-A879994DEA33Q35823557-9E9FDA59-6211-46EC-B615-E65948860BB2Q36028430-CE381907-BA4B-4494-A8E0-17CD5540BB91Q36110868-2E220F3C-42BD-4665-A084-BEE3A2C09CB9Q36483395-4817E56F-2AAB-4CB4-A035-ECB025706A2AQ36669743-DCA14AB2-3204-42F6-966E-34CB42201480Q36769571-93C84509-D377-49BA-8A30-C7B61510AA0DQ37205269-F7D95766-7790-401E-A348-A714E11B8B1DQ38630130-9A8956C6-84E1-48E7-9F1C-EF760C14AE92Q38840222-EDF90D7B-89E1-4C9F-B09E-2B8C54CA6662Q38856896-5985D11D-2179-45E1-AD52-1A0C2E36A8DCQ38943318-F62D28F5-7C99-4044-99F2-CB6590DEFF17Q39259257-872F25C2-49AA-471C-B79F-0A8331C961C4Q40130285-8040F8B6-6E15-4086-99AE-575DA58A2D21Q40135396-F3FF5059-9933-4621-817F-FE5F89503522Q40209808-80F47A01-1129-4E19-9EA3-4C2B0BD78E0EQ40245207-69DB345C-AE49-4B3C-9760-042B8861BAAEQ40344259-A101DB29-0D97-485F-B2B3-4FD3405E428DQ40445222-9C9A7A25-6516-4DE8-A694-68030C08B537Q40569274-F216DC1A-47B4-400B-83D9-3975195941E3Q40624809-ABF1B8AD-532D-422F-8219-4C54936C976C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Patrizia Carrieri
@ast
Patrizia Carrieri
@en
Patrizia Carrieri
@es
Patrizia Carrieri
@nl
Patrizia Carrieri
@sl
type
label
Patrizia Carrieri
@ast
Patrizia Carrieri
@en
Patrizia Carrieri
@es
Patrizia Carrieri
@nl
Patrizia Carrieri
@sl
prefLabel
Patrizia Carrieri
@ast
Patrizia Carrieri
@en
Patrizia Carrieri
@es
Patrizia Carrieri
@nl
Patrizia Carrieri
@sl
P106
P1153
15749979300
P21
P31
P496
0000-0002-6794-4837